Johnson Investment Counsel’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-19,107
Closed -$3.52M 602
2020
Q1
$3.52M Buy
19,107
+9,406
+97% +$1.77M 0.08% 127
2019
Q4
$1.85M Sell
9,701
-766
-7% -$138K 0.03% 207
2019
Q3
$1.76M Buy
10,467
+7,381
+239% +$1.2M 0.04% 203
2019
Q2
$516K Sell
3,086
-674
-18% -$93.3K 0.01% 417
2019
Q1
$550K Sell
3,760
-153
-4% -$22.2K 0.01% 397
2018
Q4
$523K Sell
3,913
-1,803
-32% -$296K 0.01% 395
2018
Q3
$1.09M Buy
5,716
+142
+3% +$26.1K 0.02% 310
2018
Q2
$929K Sell
5,574
-582
-9% -$93.4K 0.02% 319
2018
Q1
$1.03M Sell
6,156
-5,335
-46% -$895K 0.03% 273
2017
Q4
$1.88M Sell
11,491
-4,421
-28% -$793K 0.05% 188
2017
Q3
$3.26M Buy
15,912
+447
+3% +$104K 0.09% 145
2017
Q2
$3.76M Sell
15,465
-487
-3% -$114K 0.1% 125
2017
Q1
$3.81M Buy
15,952
+687
+5% +$160K 0.11% 126
2016
Q4
$3.21M Sell
15,265
-6,072
-28% -$1.26M 0.1% 136
2016
Q3
$4.91M Sell
21,337
-388
-2% -$94.8K 0.16% 104
2016
Q2
$5.02M Buy
21,725
+642
+3% +$148K 0.17% 104
2016
Q1
$5.65M Buy
21,083
+231
+1% +$66.1K 0.2% 90
2015
Q4
$6.52M Buy
20,852
+228
+1% +$67.9K 0.23% 85
2015
Q3
$5.61M Buy
+20,624
New +$6.34M 0.21% 89
2015
Q2
Sell
-17,507
Closed -$5.21M 560
2015
Q1
$5.21M Sell
17,507
-242
-1% -$69K 0.17% 98
2014
Q4
$4.57M Buy
17,749
+689
+4% +$172K 0.15% 105
2014
Q3
$4.12M Buy
+17,060
New +$3.82M 0.14% 107

Other funds holding AGN

Johnson Investment Counsel's AGN Position: Q2 2020 in Review

Johnson Investment Counsel sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 19,107 shares — an estimated $3.52M sold.

Johnson Investment Counsel first reported a position in AGN in Q3 2014 and held it in 22 quarters. The position peaked at $6.52M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Johnson Investment Counsel reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Johnson Investment Counsel sold 19,107 Allergan plc shares in Q2 2020, an estimated $3.52M.
  • Johnson Investment Counsel first reported a position in Allergan plc in Q3 2014 and held it in 22 quarters.
  • Johnson Investment Counsel's Allergan plc position peaked at $6.52M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Johnson Investment Counsel's 13F filing for Q2 2020, filed 13 Aug 2020.